US Broker Ratings

InMode Ltd. (INMD) Stock Analysis: Exploring a 22% Upside Potential in the Medical Devices Sector

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specializes in the development and marketing of innovative medical devices. Based in Yokne’am, Israel, the..

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: Exploring a Potential 135% Upside for Biotech Investors

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is capturing the attention of investors with its ambitious approach to brain health disorders and an enticing potential upside of..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Strong Buy Ratings and Potential Upside

Castle Biosciences, Inc. (NASDAQ: CSTL), a pioneering molecular diagnostics company headquartered in Friendswood, Texas, is catching the attention of investors with its robust portfolio of diagnostic..

Beta Bionics, Inc. (BBNX): Investor Outlook with 10.21% Upside Potential

Beta Bionics, Inc. (NASDAQ: BBNX) is making waves in the healthcare sector with its innovative approach to diabetes management. Based in Irvine, California, this medical device..

SIGA Technologies Inc. (SIGA) Stock Analysis: Unpacking the High Forward P/E and Strong ROE in a Challenging Market

SIGA Technologies Inc. (SIGA), a key player in the healthcare sector, operates within the specialized domain of drug manufacturing, focusing on antiviral solutions. The company, headquartered..

SI-BONE, Inc. (SIBN) Stock Analysis: Capitalizing on a 33% Potential Upside in the Medical Devices Sector

SI-BONE, Inc. (NASDAQ: SIBN), operating in the healthcare sector, has carved a niche for itself in the medical devices industry by focusing on innovative solutions to..

Taysha Gene Therapies, Inc. (TSHA) Stock Report: Analyzing a 152% Potential Upside in Gene Therapy Innovation

Taysha Gene Therapies, Inc. (TSHA) is gaining significant attention within the biotechnology sector for its pioneering work in gene therapy aimed at treating monogenic diseases of..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Exploring a Promising 36% Upside Potential

Cogent Biosciences, Inc. (NASDAQ: COGT), a promising player in the biotechnology sector, is attracting significant attention from investors, particularly due to its innovative approach to precision..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 159% Upside Potential for Investors

LifeMD, Inc. (NASDAQ: LFMD), a rising player in the healthcare sector, presents a compelling investment opportunity with its direct-to-patient telehealth services. Incorporated in 1994 and headquartered..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 165% Upside in the Biotech Arena

Sana Biotechnology, Inc. (NASDAQ: SANA), an emerging player in the healthcare sector with a focus on biotechnology, is capturing investor attention with its innovative approach to..

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: Unveiling a Potential 179% Upside

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a cutting-edge player in the biotechnology sector, is making waves with its ambitious approach to genome editing. As a clinical-stage company..

Claritev Corporation (CTEV) Stock Analysis: A High-Reward Opportunity with 87.93% Potential Upside

Claritev Corporation (CTEV), a company rooted in the healthcare sector, specifically within health information services, has captured the attention of investors with its innovative approach to..

CorMedix Inc. (CRMD): A Biotech Stock with a Promising 95% Upside Potential

Investors seeking growth opportunities in the biotechnology sector may find CorMedix Inc. (NASDAQ: CRMD) a compelling consideration. As a U.S.-based healthcare innovator, CorMedix focuses on developing..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Unpacking the 16.98% Potential Upside in the Diagnostics Sector

As the healthcare industry continues to evolve, Fulgent Genetics, Inc. (NASDAQ: FLGT) emerges as a noteworthy player in the diagnostics and research sector. Situated in the..

AMN Healthcare Services Inc (AMN): Investor Outlook Highlights 35% Potential Upside

AMN Healthcare Services Inc (NYSE: AMN), a key player in the medical care facilities industry, offers a wide array of technology-enabled healthcare workforce solutions. Based in..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Promising 25% Potential Upside with Robust Buy Ratings

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is making waves in the biotechnology sector, drawing investor attention with its promising pipeline and significant market potential. With a market..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Decoding the 180% Potential Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stands at a pivotal juncture within the biotechnology sector, capturing investor interest with its ambitious gene therapy programs aimed at tackling..

Anavex Life Sciences Corp. (AVXL) Investor Outlook: Exploring a 594% Potential Upside in the Biotechnology Sector

Anavex Life Sciences Corp. (NASDAQ: AVXL), a promising player in the biotechnology sector, is making waves with its ambitious focus on treating complex neurodegenerative and neuropsychiatric..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Exploring a Massive 255% Potential Upside

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is capturing investor attention with its promising therapeutic pipeline and a remarkable potential upside of 255.50%. As a biopharmaceutical company specializing..

AxoGen, Inc. (AXGN) Stock Analysis: A 23.5% Revenue Growth Propels Positive Investor Outlook

AxoGen, Inc. (NASDAQ: AXGN) is capturing the attention of investors in the healthcare sector, particularly within the medical devices industry, where its innovative approaches to peripheral..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds